(Q40552783)

21 September 2017

title

Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis (English)

1 reference

21 September 2017

0 references

F Moulin

1

1 reference

21 September 2017

H Sauvé-Martin

2

1 reference

21 September 2017

E Marc

3

1 reference

21 September 2017

Mathie M Lorrot

4

1 reference

21 September 2017

M Soulier

5

1 reference

21 September 2017

S Ravilly

6

1 reference

21 September 2017

J Raymond

7

1 reference

21 September 2017

D Gendrel

8

1 reference

21 September 2017

language of work or name

French

0 references

publication date

1 July 2003

1 reference

21 September 2017

published in

Archives de Pediatrie

1 reference

21 September 2017

volume

10

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

608-614

1 reference

Quinolone antibiotics in the treatment of Salmonella infections.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Use of pefloxacin after failure of initial antibiotic treatment in children with severe salmonellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Fluoroquinolones in paediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Ciprofloxacin safety in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Ciprofloxacin for treatment of severe typhoid fever in children

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Quinolones in children with invasive salmonellosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Side-effects of pefloxacin in idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Fluoroquinolone toxicity profiles: a review focusing on newer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Quinolone arthropathy in animals versus children

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0929-693X%2803%2900281-1

1 reference

7 January 2021

10.1016/S0929-693X(03)00281-1

Identifiers

DOI

1 reference

21 September 2017

1 reference